NCT07118566View on ClinicalTrials.gov

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

September 30, 2029

Conditions
Gastrointestinal CancerImmunotherapyLiver Metastasis
Interventions
PROCEDURE

Hyperthermia

Each session of hyperthermia should be spaced at least 24 hours apart, with at least one session administered prior to ICI (immune checkpoint inhibitor) treatment. Five times q3w.

DRUG

Immunotherapy

iv，d1，q3w

All Listed Sponsors
lead

China Medical University, China

OTHER